Nano-Targeted Delivery of Immune Therapeutics in Type 1 Diabetes

By
Laurisa Dohm
-
0
181
The authors developed a novel and specific nanodelivery platform for T1D that targeted high endothelial venules presented in the pancreatic lymph nodes and pancreas.
[Advanced Materials]
Abstract